8-KThe WireRoutine
Bylaw Amendment
Filed Oct 3, 2024 · 1y ago · Accession 0001193125-24-232306
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Vanda Pharmaceuticals Inc.
- Ticker
- VNDA
- CIK
- 1347178
- Form type
- 8-K
- Filing date
- Oct 3, 2024
- Report date
- Oct 2, 2024
- Document
- d828148d8k.htm
- Size
- 388 KB